Anzeige
Mehr »
Login
Sonntag, 16.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Kennen wir bei East Africa bislang nur die Spitze des Goldberges?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HJF | ISIN: US9314271084 | Ticker-Symbol: W8A
Tradegate
14.06.24
21:58 Uhr
14,480 Euro
-0,050
-0,34 %
1-Jahres-Chart
WALGREENS BOOTS ALLIANCE INC Chart 1 Jahr
5-Tage-Chart
WALGREENS BOOTS ALLIANCE INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,31014,67019:02
14,43414,58814.06.
ACCESSWIRE
532 Leser
Artikel bewerten:
(2)

Walgreens Boots Alliance: Women in Clinical Trials: 5 Quotes To Inspire Action

Walgreens hosted a Clinical Trials Day event in the Boston area this week where the emphasis was on women's health in the transformation of clinical trials and healthcare innovation.

Originally published by Walgreens Boots Alliance

By Elyse Russo

NORTHAMPTON, MA / ACCESSWIRE / May 24, 2024 / Clinical Trials Day is globally recognized on May 20, and this year, the Walgreens Clinical Trials team decided to celebrate with an event dedicated to women's health. After all, May is National Women's Health Month.

"Walgreens is taking action to elevate awareness about gender-specific disparities related to health, and the importance and relevance of participation in medical research," said Kendal Whitlock, head of digital optimization for Walgreens Clinical Trials.

Whitlock was the organizer of the Walgreens Clinical Trials Day event, which was held earlier this week in the Boston area-a timely location as Walgreens just announced that a new clinical trials center will be opening in the nearby city of Malden.

Doctors, pharmacists, community leaders, advocates, academics, tech companies and pharmaceutical organizations were all represented at the Walgreens Clinical Trials event. The day was kicked off with remarks from local Congressman Jake Auchincloss, and featured keynote speakers and panels. Many of the women who participated in the Clinical Trials Day event made bold statements about the state of women's health and how to support women's inclusion in medical research. Here are just five of their inspirational quotes.

1. "Let's make some noise."

Walgreens Chief Clinical Trials Officer Ramita Tandon shared a Walgreens clinical trials milestone that shows the company's commitment to including women in medical research:

"As the two-year anniversary of our clinical trials business approaches, we celebrate reaching more than 4 million patients to potentially enroll into trials, and of those, more than 60% have been women. We will continue to make strides to bring trials directly to our communities and continue dialing up the noise on women's health."

2. "Ask and explain."

Dr. Yvette Cozier is an investigator on the Black Women's Health Study (BWHS) and the BWHS Sarcoidosis Study at the Slone Epidemiology Center, Boston University. During her keynote, Cozier talked about how to best recruit Black women for clinical trials:

"In my research, I've learned that Black women want to participate in clinical research. You just have to package information so that someone like my grandmother would understand it and do it. If you ask women and explain things to them, they will join clinical trials."

3. "Looking back informs how to look forward."

Dr. Bayo Curry-Winchell, who serves as the medical director of urgent care clinics at Saint Mary's Regional Medical Center in Reno, Nevada, says history should inform healthcare professionals how we can push forward in women's health.

"True diversity in healthcare goes beyond token representation. Acknowledging our history is essential to equip ourselves with insights needed to address trust and prevent delayed care. Afterall, our past still impacts how we're bringing healthcare to women. The National Institutes of Health reported it takes up to 17 years for new evidence to translate into standard clinical practice, which means we're still using practices studied more than 17 years ago."

4. "Inclusion in the standard of care."

Epidemiologist Linda Goler Blount, who is also president and CEO of the Black Women's Health Imperative, wants women to feel confident in knowing they are included in developing the standard of care.

"When we say something is evidence based, I want the women I'm talking to to know that the standard of care was created with them in mind and that they were involved in the research."

5. "Healthy women should matter to everyone."

Dr. Beth Garner, who is Chief Scientific Officer of Ferring Pharmaceuticals US, makes the case for why women's health is a topic everyone should care about.

"We all know that when women are healthy, everyone is healthy. That's why it's important to include people in clinical trials who look like the people who will be using your product when it's approved. That is why it's so amazing what Walgreens is doing in clinical trials. It's so exciting to bring clinical trials to the people."

Visit Walgreens.com to learn more about Walgreens Clinical Trials.



View additional multimedia and more ESG storytelling from Walgreens Boots Alliance on 3blmedia.com.

Contact Info:
Spokesperson: Walgreens Boots Alliance
Website: https://www.3blmedia.com/profiles/walgreens-boots-alliance
Email: info@3blmedia.com

SOURCE: Walgreens Boots Alliance



View the original press release on accesswire.com

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2024 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.